Study Shows Tumor Oxygenation and Radiation Enhancement Using RSR13 And Potential Role as Imaging Agent
Allos Therapeutics, Inc. today announced the publication of study results that demonstrate the application of blood oxygen level-dependent magnetic resonance imaging to noninvasively quantitate the temporal and dose-dependent ability of RSR13 to increase tumor oxygenation of human non-small cell lung cancer tumors grown in mice.
Sep 20 11:26 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010920/lath061_1.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines